Latest Financial Health News

WT Financial Group has delivered a robust half-year performance with underlying net revenue up 19.3% and net profit after tax rising 14.4%, driven by adviser productivity and strategic investments.

AMP Limited has announced an ordinary dividend of AUD 0.02 per share for the half-year ending December 2025, partially franked at 20%, with payments scheduled for April 2026.

South32 Limited has announced a fully franked ordinary dividend of USD 0.039 per share for the six months ending December 2025, payable in multiple currencies on April 2, 2026.

Orora Limited has announced an ordinary unfranked dividend of AUD 0.05 per share for the six months ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Breville Group Limited has reported a record half-year revenue of AUD 1.1 billion, overcoming US tariff challenges through strategic manufacturing shifts and robust product innovation. The company’s steady profitability and geographic expansion signal a confident growth trajectory.

Breville Group Limited has announced a fully franked ordinary dividend of AUD 0.19 per share for the six months ending December 2025, signaling steady returns for shareholders.

Kingsgate Consolidated capped a transformational 2025 with a 344% share price surge and strong cash position, setting ambitious production and exploration targets for 2026.

Seven West Media’s H1 FY26 results align with guidance, showing resilience in a declining TV advertising market and strong digital growth.

StepChange Holdings has reported robust organic growth with a 19% revenue increase in its first half as an ASX-listed company, complemented by a strategic acquisition expanding its government sector presence.

Eden Innovations has appointed Dr Allan Godsk Larsen as Managing Director to spearhead its global growth, leveraging his deep expertise in carbon nanotube technology amid strong commercial momentum and significant debt reduction.

Regal Partners has launched a $75 million on-market share buy-back program, signalling strong confidence in its financial health and growth prospects. The buy-back aims to enhance shareholder value while preserving capital for strategic opportunities.

Jcurve Solutions has reported a robust Q2FY26 with a significant profit turnaround and a confident revenue outlook for FY26, driven by strong sales and recurring revenue growth.